tiprankstipranks
Trending News
More News >

Telo Genomics Broadens Partnership with Mayo Clinic

Story Highlights
Telo Genomics Broadens Partnership with Mayo Clinic

Telo Genomics Corp (TSE:TELO) has released an update.

Don’t Miss TipRanks’ Half-Year Sale

Telo Genomics Corp has expanded its collaboration with Mayo Clinic to enhance the development of its TeloView diagnostic tests for multiple myeloma, aiming to improve patient outcomes and commercialize its innovative technologies. The partnership includes the validation of TeloViewNDMM, a test for predicting the relapse of newly diagnosed multiple myeloma patients, as a Laboratory Developed Test (LDT).

For further insights into TSE:TELO stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1